好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Modified Frailty Index-11 (mFI-11) Measured Frailty as a Predictor of Postoperative Outcomes in Parkinson's Disease Patients Undergoing Deep Brain Stimulation: A National Inpatient Sample Analysis
Movement Disorders
S32 - Movement Disorders: Neuroimaging and Neuromodulation (5:18 PM-5:30 PM)
010
PD presents with tremor, rigidity, bradykinesia, and postural instability. Commonly, PD is diagnosed around age 60 with the rate of diagnosis increasing with age. DBS is an invasive surgical treatment for PD. Inherently, older patients are more frail than younger patients and may experience more negative outcomes with DBS.

Use frailty as a predictor of postoperative outcomes in Parkinson’s Disease (PD) patients undergoing deep brain stimulation (DBS) using the Nationwide Inpatient Sample (NIS).

This retrospective cohort study analyzed NIS data from 2016-2020, identifying PD patients who received DBS. Frailty was determined using the 11-item mFI-11, with patients classified into frail and non-frail groups. Primary outcomes included prolonged length of stay (LOS) beyond the 75th percentile, non-routine discharge, and postoperative complications. Secondary outcomes involved total hospital costs. Univariate and multivariate analyses were performed, adjusting for demographics, comorbidities (CCI), and hospital characteristics.

A total of 3,545 patients met the inclusion criteria. Frailty was associated with significantly higher odds of unfavorable discharge (aOR: 1.80, 95% CI: 1.47–2.20, p < 0.001), prolonged LOS (aOR: 2.01, 95% CI: 1.59–2.57, p < 0.001), and postoperative complications (OR: 1.57, 95% CI: 1.45–1.70, p < 0.001). In the lower CCI group, frailty was significantly associated with both prolonged LOS (aOR: 1.63, 95% CI: 1.25–2.13) and non-routine discharge (aOR: 1.47, 95% CI: 1.18–1.84). Among patients with higher CCI scores, frail patients also had increased odds of unfavorable outcomes, though less pronounced. Frailty was linked to an additional $6,588 in hospital costs (p = 0.004).

Frailty is a strong predictor of adverse outcomes in PD patients undergoing DBS, including prolonged LOS, non-routine discharge, and postoperative complications. These findings suggest that incorporating frailty assessments into preoperative planning may improve outcomes and reduce healthcare costs.

Authors/Disclosures
Kaitlyn E. Heintzelman, MD/PhD Student
PRESENTER
Ms. Heintzelman has nothing to disclose.
David Fletcher Mr. Fletcher has nothing to disclose.
Abdul H. Khan, MBBS Dr. Khan has nothing to disclose.
Umesh Ananthasayanam, MD Mr. Ananthasayanam has nothing to disclose.
Peter Konrad (West Virginia University) Peter Konrad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic.
Adeel A. Memon, MD (West Virginia University) The institution of Dr. Memon has received research support from NIH/NINDS.